BE882167A - (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique - Google Patents

(1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique

Info

Publication number
BE882167A
BE882167A BE1/9747A BE1009747A BE882167A BE 882167 A BE882167 A BE 882167A BE 1/9747 A BE1/9747 A BE 1/9747A BE 1009747 A BE1009747 A BE 1009747A BE 882167 A BE882167 A BE 882167A
Authority
BE
Belgium
Prior art keywords
butylamines
biphenyl
propyl
preparation
therapeutic use
Prior art date
Application number
BE1/9747A
Other languages
English (en)
Inventor
W B Lacefield
R L Simon
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BE882167A publication Critical patent/BE882167A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/092—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings with aromatic radicals attached to the chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
BE1/9747A 1979-03-12 1980-03-11 (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique BE882167A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US1953479A 1979-03-12 1979-03-12

Publications (1)

Publication Number Publication Date
BE882167A true BE882167A (fr) 1980-09-11

Family

ID=21793713

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/9747A BE882167A (fr) 1979-03-12 1980-03-11 (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique

Country Status (31)

Country Link
EP (1) EP0015776B1 (fr)
JP (1) JPS55127347A (fr)
KR (1) KR840000103B1 (fr)
AR (1) AR228852A1 (fr)
AT (1) AT367395B (fr)
AU (1) AU528060B2 (fr)
BE (1) BE882167A (fr)
CA (1) CA1144926A (fr)
CH (1) CH644094A5 (fr)
CS (1) CS215052B2 (fr)
DD (1) DD149664A5 (fr)
DE (1) DE3060611D1 (fr)
DK (1) DK103480A (fr)
ES (6) ES8105262A1 (fr)
FI (1) FI800736A (fr)
FR (1) FR2451363A1 (fr)
GB (1) GB2046256B (fr)
GR (1) GR68036B (fr)
HU (1) HU180334B (fr)
IE (1) IE49552B1 (fr)
IL (1) IL59557A (fr)
IT (1) IT1140773B (fr)
LU (1) LU82237A1 (fr)
MX (1) MX6219E (fr)
NZ (1) NZ193079A (fr)
PH (1) PH14749A (fr)
PL (1) PL121662B1 (fr)
PT (1) PT70928A (fr)
RO (1) RO79906A (fr)
SU (2) SU940645A3 (fr)
ZA (1) ZA801421B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100470454B1 (ko) * 2002-05-14 2005-02-05 대한민국 돼지 사료공급을 위한 자동조절급이기
EP1768951A4 (fr) * 2004-06-17 2011-06-15 Musc Found For Res Dev Acides amines non naturels
EP2511273B8 (fr) * 2011-04-15 2019-06-26 Hivih Inhibiteurs de la réplication virale, leur procédé de préparation et leurs utilisations thérapeutiques
EP2821104A1 (fr) 2013-07-05 2015-01-07 Laboratoire Biodim Inhibiteurs de la réplication virale, leur procédé de préparation et leurs utilisations thérapeutiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES236010A1 (es) * 1956-06-29 1957-12-16 Lab Pharmaceutica Dr C Janssen UN PROCEDIMIENTO PARA PREPARAR NUEVOS DERIVADOS PARASIMPATICOLiTICAMENTE ACTIVOS DE ALFAS-DEFENIL PROPANO
US3433836A (en) * 1966-01-14 1969-03-18 Rexall Drug Chemical Alpha-diaryl alpha,omega-alkylene glycol-dilower-alkylamines
GB1475314A (en) * 1973-11-02 1977-06-01 Cm Ind Phenyl-propylamine derivatives
IL48319A0 (en) * 1974-10-26 1975-12-31 Merck Patent Gmbh Araliphatic nitrogen compounds and a process for their preparation
GB1523655A (en) * 1975-02-10 1978-09-06 Armour Pharma 4-(4-biphenylyl) butylamines and treatment of the animal organism therewith

Also Published As

Publication number Publication date
PL222601A1 (fr) 1981-01-30
ES8201528A1 (es) 1981-12-16
ES497206A0 (es) 1981-12-16
SU940645A3 (ru) 1982-06-30
DE3060611D1 (en) 1982-08-19
ES497207A0 (es) 1981-12-16
JPS55127347A (en) 1980-10-02
EP0015776A1 (fr) 1980-09-17
DK103480A (da) 1980-09-13
ES497210A0 (es) 1981-12-16
RO79906A (fr) 1982-10-11
GB2046256A (en) 1980-11-12
IT1140773B (it) 1986-10-10
IE800493L (en) 1980-09-12
ES489469A0 (es) 1981-05-16
NZ193079A (en) 1982-05-31
PL121662B1 (en) 1982-05-31
PT70928A (en) 1980-04-01
ATA134580A (de) 1981-11-15
CH644094A5 (fr) 1984-07-13
GB2046256B (en) 1983-04-20
HU180334B (en) 1983-02-28
IL59557A (en) 1983-10-31
ES8201525A1 (es) 1981-12-16
AR228852A1 (es) 1983-04-29
ES497208A0 (es) 1981-12-16
FR2451363A1 (fr) 1980-10-10
ES8105262A1 (es) 1981-05-16
IE49552B1 (en) 1985-10-30
CS215052B2 (en) 1982-07-30
ES8201527A1 (es) 1981-12-16
AU5630280A (en) 1980-09-18
EP0015776B1 (fr) 1982-06-30
ES8201526A1 (es) 1981-12-16
KR830001854A (ko) 1983-05-19
MX6219E (es) 1984-12-21
ZA801421B (en) 1981-10-28
IL59557A0 (en) 1980-06-30
FI800736A (fi) 1980-09-13
IT8020503A0 (it) 1980-03-11
ES497209A0 (es) 1981-12-16
ES8201529A1 (es) 1981-12-16
AT367395B (de) 1982-06-25
AU528060B2 (en) 1983-04-14
KR840000103B1 (ko) 1984-02-11
CA1144926A (fr) 1983-04-19
LU82237A1 (fr) 1980-06-06
PH14749A (en) 1981-11-20
DD149664A5 (de) 1981-07-22
SU1022655A3 (ru) 1983-06-07
FR2451363B1 (fr) 1983-01-14
GR68036B (fr) 1981-10-27

Similar Documents

Publication Publication Date Title
LU81439A1 (fr) Octahydro-pyrazolo(3,4-g)quinoleines et leur utilisation therapeutique
BE873883A (fr) 6-n-propyl-8-methoxymethyl ou methylmercaptomethylergolines et composes apparentes, et leur utilisation therapeutique
BE884300A (fr) Amides, leur preparation et leur utilisation
FR2487349B1 (fr) Derives de l'hydronaphtalene, leur preparation et leur utilisation en therapeutique
LU81458A1 (fr) Phenethanolamines et leur utilisation therapeutique
LU80922A1 (fr) 9-amino-et imino-dibenzopyrannes et leur utilisation therapeutique
BE882601A (fr) Mercaptoacyldipeptides, leur preparation et leur utilisation
BE869509A (fr) Pyrazoles substitues en position 4, leur preparation et leur utilisation therapeutique
BE882166A (fr) 9-aminoalkylfluorenes, leur preparation et leur utilisation therapeutique
BE880220A (fr) 1,2,4,5-tetra-alkyl-4-arylpiperidines, leur utilisation therapeutique, leur preparation et les intermediaires appropries
BE872134A (fr) Nouvelles indolo (2,3,a) quinolizidines, leur preparation et leur utilisation therapeutique
BE885117A (fr) 3-amino-oxazolidin-2-ones, leur preparation et leur utilisation
BE886676A (fr) Pentapeptides homologues d'enkephalines, leur preparation et leur utilisation therapeutique
BE872990A (fr) Trans-4a-aryl-octahydro-1h-2-pyrindines et leur utilisation therapeutique
BE866728A (fr) 1,2,4-triazoles, leur preparation et leur utilisation
BE877328A (fr) Octahydro-2h-pyrrolo (3,4-g) quinoleines et leur utilisation therapeutique
BE891585A (fr) 5 alpha-androstane-17 beta-carboxylates et 5 beta-androstane-17 beta-carboxylates, leur preparation et leur utilisation
LU81437A1 (fr) 2-azaergolines et 2-aza-8(ou 9)ergolenes et leur utilisation therapeutique
BE882167A (fr) (1,1-biphenyl-2-yl)-propyl- et butylamines, leur preparation et leur utilisation therapeutique
BE874430A (fr) 2,3-dihydroimidazo (1,2,c) pyrimidines substituees et leur utilisation therapeutique
BE884990A (fr) Thiadiazine-amines, leur preparation et leur utilisation
BE876680A (fr) Arylalkyl- et aryloxyalkyl- phosphonates, leur preparation et leur utilisation therapeutique
LU80161A1 (fr) 2,1-benzisothiazoles,leur preparation et leur utilisation therapeutique
BE871724A (fr) 4-desacetoxy-4 alpha-hydroxyindole-dihydroindoles et leur utilisation therapeutique
BE880288A (fr) Hexahydro-2,6-methano-3-benzazocines, leur preparation et leur utilisation therapeutique

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ELI LILLY AND CY

Effective date: 19870331